Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rxsight Inc
(NQ:
RXST
)
46.04
-1.18 (-2.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rxsight Inc
< Previous
1
2
3
4
Next >
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
July 16, 2024
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?
Via
Benzinga
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
July 15, 2024
Via
Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 10, 2024
Via
Benzinga
Why RxSight (RXST) Shares Are Falling
May 09, 2024
RxSight shares are trading lower by 5.6% during Thursday's session. The company announced pricing of its $100 million proposed public offering of common stock.
Via
Benzinga
What 10 Analyst Ratings Have To Say About RxSight
May 07, 2024
Via
Benzinga
Assessing RxSight: Insights From 8 Financial Analysts
April 11, 2024
Via
Benzinga
Forecasting The Future: 9 Analyst Projections For RxSight
February 29, 2024
Via
Benzinga
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
June 05, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Do You Have Your Eye On Vision Care Stocks?
May 20, 2024
For investors seeking stable and growing opportunities, eye care stocks are an attractive option.
Via
Talk Markets
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 13, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
May 08, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Recap: RxSight Q4 Earnings
February 28, 2024
Via
Benzinga
RxSight, Inc. Announces Proposed Public Offering of Common Stock
May 08, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
RXST stock results show that RxSight beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
RxSight, Inc. Reports First Quarter 2024 Financial Results
May 06, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight's Earnings Outlook
February 27, 2024
Via
Benzinga
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
February 12, 2024
Via
Benzinga
The Analyst Landscape: 8 Takes On RxSight
January 29, 2024
Via
Benzinga
RxSight, Inc. to Present at the Bank of America Healthcare Conference
May 01, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
April 22, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
April 04, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 27, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Chart Of The Day: RxSight - Cashing In On Cataracts
March 04, 2024
Earnings are estimated to increase 33.30% this year, increase an additional 26.60% next year and continue to compound at an annual rate of 19.00% for the next 5 years
Via
Talk Markets
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
February 29, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 28, 2024
February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
Via
Benzinga
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 14, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Insiders are selling these hot stocks on track for higher prices
February 07, 2024
Insiders are selling these hot stocks and may cap gains in the near term, but long-term gains are in the outlook. Analysts support them and raise their targets.
Via
MarketBeat
Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month
January 25, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky."
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.